Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3070-3080

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-02 ,pp. : 7-18

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1410-1416

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

By  

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4326-4341

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 824-833

Bentham Science Publishers

Access to resources Recommend Favorite